Company Overview of RNL Europe GmbH
As of 2013, RNL Europe GmbH went out of business. RNL Europe GmbH operates as a research organization that develops stem cell-based therapies for the treatment of autoimmune disorders. The company was formerly known as Pharmicell Europe GmbH and changed its name to RNL Europe GmbH, following its acquisition by K-STECMCELL CO.,Ltd. in January 2011. RNL Europe GmbH was founded in 2006 and is based in Berlin, Germany.
Founded in 2006
49 30 3393 5994
49 30 3393 5996
Key Executives for RNL Europe GmbH
RNL Europe GmbH does not have any Key Executives recorded.
Similar Private Companies By Industry
|4 Animals AlsterScience GmbH||Europe|
|Acousia Therapeutics GmbH||Europe|
|Across Barriers GmbH||Europe|
|Actinodrug Pharmaceuticals GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact RNL Europe GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.